झोटा हेल्थकेअर शेअर किंमत

झोटा हेल्थकेअर इन्व्हेस्टमेंट रेटिंग

• मास्टर रेटिंग:

• Zota Healthcare Ltd. manufactures and markets pharmaceutical formulations, including tablets, capsules, and syrups. The company operates in India and exports to international markets, offering a wide range of affordable medicines for healthcare, wellness, and nutritional needs. Zota Health Care Ltd has an operating revenue of Rs. 198.14 Cr. on a trailing 12-month basis. An annual revenue growth of 28% is outstanding, Pre-tax margin of -9% needs improvement, ROE of -15% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 9% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 1 which is a POOR score indicating inconsistency in earnings, a RS Rating of 55 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at C- which is evident from recent supply seen, Group Rank of 35 indicates it belongs to a strong industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment. Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.